New study reveals rare genetic variants significantly increase atrial fibrillation risk

FHS
June 28, 2024
5:19 am

Researchers identified rare genetic variants that significantly increase the risk of atrial fibrillation, enhancing AF risk stratification by combining these with polygenic risk scores.

Stopping Tirzepatide Led to Weight Gain, Trial Shows

After discontinuing the weight-management injectable tirzepatide (Zepbound), most patients had a hard time keeping the weight off during the phase III SURMOUNT-4 trial. People on

December 14, 2023

New research challenges current practices for premature babies

Giving very premature babies high concentrations of oxygen soon after birth may reduce the risk of death by 50 percent, compared to lower levels of

June 25, 2024

FDA approves Sun Pharma’s JAK inhibitor for alopecia – Pharmaceutical Technology

Alopecia areata occurs when the immune system attacks hair follicles and causes hair loss. Credit: Brester Irina via Shutterstock. Sun Pharmaceutical Industries has secured the

July 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.